| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 23 |
| 1 | HYDROCHLOROTHIAZIDE | 21 |
| 2 | AZITHROMYCIN DIHYDRATE | 18 |
| 3 | ALBUTEROL | 17 |
| 4 | AMPHOTERICIN B | 16 |
| 5 | ACLIDINIUM BROMIDE | 15 |
| 6 | AZITHROMYCIN | 15 |
| 7 | AZITHROMYCIN MONOHYDRATE | 15 |
| 8 | FLUTICASONE FUROATE | 15 |
| 9 | RITUXIMAB | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAFCILLIN SODIUM | 3 | 0.0033 |
| 1 | CEFTOLOZANE AND TAZOBACTAM | 3 | 0.0031 |
| 2 | ACLIDINIUM BROMIDE | 15 | 0.0023 |
| 3 | AMPHOTERICIN B | 16 | 0.0012 |
| 4 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 5 | BENDAMUSTINE HCL | 13 | 0.0008 |
| 6 | BACITRACIN | 3 | 0.0008 |
| 7 | MICAFUNGIN SODIUM | 5 | 0.0008 |
| 8 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 9 | TAMOXIFEN CITRATE | 3 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 30 |
| 1 | Thiazide Diuretic [EPC] | 21 |
| 2 | Polyene Antifungal [EPC] | 17 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 16 |
| 4 | Osmotic Laxative [EPC] | 16 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 15 |
| 6 | Alkylating Drug [EPC] | 14 |
| 7 | Azole Antifungal [EPC] | 13 |
| 8 | Potassium Salt [EPC] | 13 |
| 9 | Atypical Antipsychotic [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 16 | 0.0012 |
| 1 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 2 | Polyene Antifungal [EPC] | 17 | 0.0004 |
| 3 | Antimalarial [EPC] | 4 | 0.0004 |
| 4 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 5 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 6 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 3 | 0.0002 |
| 7 | Recombinant Human Deoxyribonuclease 1 [EPC] | 3 | 0.0002 |
| 8 | Bile Acid [EPC] | 3 | 0.0001 |
| 9 | Thiazide Diuretic [EPC] | 21 | 0.0001 |